Hostname: page-component-76d6cb85b7-hqrjx Total loading time: 0 Render date: 2026-07-21T02:01:40.931Z Has data issue: false hasContentIssue false

Evaluating HTA principles

Published online by Cambridge University Press:  13 October 2010

Peter J. Neumann
Affiliation:
Director, Center for the Evaluation of Value & Risk, in Health, Institute for Clinical Research and Health Policy Studies, 800 Washington Street, Tufts Medical Center, #063, Professor, Tufts University School of Medicine, Boston, Massachusetts 02111 Email: pneumann@tuftsmedicalcenter.org
Michael F. Drummond
Affiliation:
Professor, Health Economics, Centre for Health Economics, University of York, Alcuin A Block, Heslington, York YO10 5DD, United Kingdom Email: md18@york.ac.uk
Bengt Jonsson
Affiliation:
Professor, Department of Economics, Stockholm School of Economics, 65, Sveavagen, Stockholm, SE 11383 Sweden Email: Bengt.Jonsson@hhs.se
Bryan R. Luce
Affiliation:
Senior Vice President, Department of Science Policy, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, Maryland 20817 Email: bryan.luce@unitedbiosource.com
J. Sanford Schwartz
Affiliation:
Leon Hess Professor of Medicine, Health Management & Economics, Departments of Medicine and Health Care Management, School of Medicine and the Wharton School, University of Pennsylvania, Blockley Hall Suite #1120, Philadelphia, Pennsylvania 19104 Email: schwartz@wharton.upenn.edu
Uwe Siebert
Affiliation:
Chair Professor of Public Health (UMIT), Department of Public Health, Medical Decision Making and Health Technology Assessment, UMIT – University for Health Sciences Medical Informatics and Technology, Eduard Wallnoefer Center I, Hall i.T., Austria, A-6060, Adjunct Professor, Department of Health Policy and Management, Harvard School of Public Health, 677 Huntington Avenue, Boston, Massachusetts 02115 Email: public-health@umit.at
Sean D. Sullivan
Affiliation:
Professor, Pharmaceutical Outcomes Research and Policy Program, University of Washington, 1959 NE Pacific Avenue, Box 357630, Seattle, Washington 98195 Email: sdsull@u.washington.edu
Rights & Permissions [Opens in a new window]

Extract

Thank you for the opportunity to respond to the letter by Gibson and Little. The authors raise several points that require a response. First, they claim that we inaccurately characterized the DERP/Washington State Medicaid agency, and did not appreciate that the DERP and the Washington State Medicaid agency have different missions. On the contrary, however, we fully recognized that DERP's mission is to conduct systematic reviews and not to make recommendations, whereas Washington State uses the reviews in making recommendations for their Medicaid enrollees. We specifically noted in the study that “Washington Medicaid is one of fourteen participants in the DERP. DERP researchers conduct health technology assessments for drug classes. Participants in the DERP, such as the Washington Medicaid program, retain local authority for interpreting DERP reports and for decision making regarding which drugs to pay for.” We chose to analyze DERP/Washington State as a single entity for our exercise because we were interested in analyzing the link between the HTA conducted and the decisions that follow them.

Information

Type
LETTERS TO THE EDITOR
Copyright
Copyright © Cambridge University Press 2010